½ÃÀ庸°í¼­
»óǰÄÚµå
1572938

¿ø°ÝÀÇ·á ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2031³â)

Telehealth Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 191 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Persistence Market Research´Â À̹ø¿¡ ¼¼°èÀÇ ¿ø°ÝÀÇ·á ¼­ºñ½º ½ÃÀå¿¡ °üÇÑ Á¾ÇÕ º¸°í¼­¸¦ ¹ßÇ¥Çß½À´Ï´Ù. º» ¸®Æ÷Æ®¿¡¼­´Â ½ÃÀå ¼ºÀå ÃËÁø¿äÀΡ¤µ¿Ç⡤±âȸ¡¤°úÁ¦¸¦ Æ÷ÇÔÇÑ Áß¿äÇÑ ½ÃÀå ¿ªÇÐÀ» öÀúÇÏ°Ô Æò°¡Çϰí, ½ÃÀå ±¸Á¶¿¡ °üÇÑ »ó¼¼ ÀλçÀÌÆ®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ Á¶»ç ¸®Æ÷Æ®´Â 2024-2031³âÀÇ ¼¼°è ¿ø°ÝÀÇ·á ½ÃÀåÀÇ ¿¹Ãø ¼ºÀå ±Ëµµ¸¦ ¼³¸íÇÏ´Â µ¶Á¡ µ¥ÀÌÅÍ¿Í Åë°è¸¦ °ÔÀçÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • ¿ø°ÝÀÇ·á ½ÃÀå ±Ô¸ð(2024³â) : 1,286¾ï ´Þ·¯
  • ¿¹Ãø ½ÃÀå ±Ý¾×(2031³â) : 4,489¾ï ´Þ·¯
  • ¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR 2024-2031³â) : 15.0%

¿ø°ÝÀÇ·á ½ÃÀå - ¸®Æ÷Æ® ¹üÀ§ :

¿ø°ÝÀÇ·á´Â °¡»ó Áø·á, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ, ¿ø°Ý Ä¡·á µî ¿ø°ÝÀ¸·Î Á¦°øµÇ´Â ÀÇ·á ¼­ºñ½ºÀÇ ±¤¹üÀ§ÇÑ ½ºÆåÆ®·³À» Æ÷°ýÇÕ´Ï´Ù. µðÁöÅÐ Åë½Å ±â¼úÀ» Ȱ¿ëÇÏ¿© ¿ø°ÝÁö¿¡¼­ ÀǷḦ Á¦°øÇÏ°í ´Ù¾çÇÑ È¯°æÀÇ È¯ÀÚ°¡ ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á ½ÃÀåÀº º´¿ø, Áø·á¼Ò, ȯÀÚ¸¦ ´ë»óÀ¸·Î ¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀ̼Ç, À¥»çÀÌÆ®, Àü¿ë ¿ø°ÝÀÇ·á ½Ã½ºÅÛ µî ´Ù¾çÇÑ Ç÷§ÆûÀ» ÅëÇØ ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº ÁÖ·Î Á¢±Ù¼º ³ôÀº ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ±â¼ú ¹ßÀü, ȯÀÚ Á᫐ Áø·á¿¡ ´ëÇÑ °ü½É Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀåÀÇ ÃËÁø¿äÀÎ:

¼¼°è ¿ø°ÝÀÇ·á ½ÃÀåÀº COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇÑ µðÁöÅÐ Çコ ¼Ö·ç¼ÇÀÇ Ã¤Åà Áõ°¡¿Í °°Àº ¸î °¡Áö ÁÖ¿ä ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖÀ¸¸ç, ÀÌ·Î ÀÎÇØ ÀÇ·áÁø°ú ȯÀÚ ¸ðµÎ ¿ø°ÝÀÇ·á ¼­ºñ½º ¼ö¿ëÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸¸¼ºÁúȯÀÇ È®»êÀ¸·Î ÀÎÇØ ȯÀÚÀÇ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇØÁö¸é¼­ ¿ø°ÝÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÎÅÍ³Ý ¿¬°áÀÇ °³¼±°ú ½º¸¶Æ®ÆùÀÇ º¸±Þ°ú °°Àº Åë½ÅÀÇ ¹ßÀüÀº ¿ø°ÝÀÇ·á ¼­ºñ½ºÀÇ ½ÇÇö °¡´É¼ºÀ» ³ô¿©ÁÖ°í ÀÖ½À´Ï´Ù. ÀÇ·á ºñ¿ë Àý°¨°ú ȯÀÚ Ä¡·á °á°ú °³¼±¿¡ ´ëÇÑ °­Á¶´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ :

À¯¸ÁÇÑ ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸ÇÏ°í ¿ø°ÝÀÇ·á ½ÃÀåÀº ±ÔÁ¦ ¹®Á¦, »óȯ Á¤Ã¥, ±â¼ú °ü·Ã À庮°ú °ü·ÃµÈ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. Áö¿ªº°·Î º¸»ó ¹üÀ§°¡ ´Ù¾çÇÏ°í ¿ø°ÝÀÇ·á ¼­ºñ½º¸¦ Áö¿øÇÏ´Â Á¤Ã¥ÀÌ ¹ÌÈíÇÑ °ÍÀº ½ÃÀå µµÀÔ¿¡ °É¸²µ¹ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ µ¥ÀÌÅÍ º¸¾È ¹× ȯÀÚ ÇÁ¶óÀ̹ö½Ã ¹®Á¦·Î ÀÎÇØ ÀϺΠȯÀÚµéÀº ¿ø°ÝÀÇ·á Ç÷§ÆûÀÇ »ç¿ëÀ» ÁÖÀúÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦¿Í ±â¼úÀû ¹®Á¦¸¦ ÇØ°áÇϱâ À§Çؼ­´Â ÀÌÇØ°ü°èÀÚµéÀÌ Çù·ÂÇÏ¿© ¿ø°ÝÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ¸íÈ®ÇÑ °¡À̵å¶óÀΰú ±âÁØÀ» ¸¶·ÃÇØ¾ß ÇÕ´Ï´Ù.

½ÃÀå ±âȸ :

¿ø°ÝÀÇ·á ½ÃÀåÀº ½Å±â¼ú, Àα¸ µ¿Çâ, ÁøÈ­ÇÏ´Â ÀÇ·á ¼­ºñ½º Á¦°ø ¸ðµ¨·Î ÀÎÇØ Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×(ML)À» ¿ø°ÝÀÇ·á Ç÷§Æû¿¡ ÅëÇÕÇϸé Áø´Ü Á¤È®µµ¿Í ȯÀÚ °ü¸®¸¦ °­È­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ °í·ÉÃþ¿¡¼­ ¿ø°ÝÀÇ·á°¡ Á¡Á¡ ´õ ¸¹ÀÌ ¹Þ¾Æµé¿©Áö°í ÀÖ´Â °ÍÀº ½ÃÀå È®´ëÀÇ »õ·Î¿î ±æÀ» ¿­¾îÁÙ °ÍÀÔ´Ï´Ù. ¿þ¾î·¯ºí ±â¼ú ¹× ¿ø°ÝÀÇ·á ¿ëµµ¸¦ Æ÷ÇÔÇÑ Çõ½ÅÀûÀÎ ¿ø°ÝÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ Àü·«Àû ÆÄÆ®³Ê½Ê°ú ÅõÀÚ´Â »õ·Î¿î ±âȸ¸¦ Ȱ¿ëÇÏ°í ½ÃÀå ¸®´õ½ÊÀ» À¯ÁöÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

  • ¼¼°è ¿ø°ÝÀÇ·á ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
  • ¾î¶² ¿ø°ÝÀÇ·á ¼­ºñ½º ¹× Ç÷§ÆûÀÌ °¡Àå ³ôÀº äÅ÷üÀ» º¸À̰í Àִ°¡?
  • ±â¼úÀÇ ¹ßÀüÀº ¿ø°ÝÀÇ·á ½ÃÀå °æÀï ±¸µµ¸¦ ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?
  • ¿ø°ÝÀÇ·á ½ÃÀå¿¡ ±â¿©Çϰí ÀÖ´Â ÁÖ¿ä ±â¾÷Àº ¾îµðÀ̸ç, ½ÃÀå °ü·Ã¼ºÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» äÅÃÇϰí Àִ°¡?
  • ¼¼°è ¿ø°ÝÀÇ·á ½ÃÀåÀÇ »õ·Î¿î µ¿Çâ°ú Àü¸ÁÀº?

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀåÀÇ ¹üÀ§¿Í Á¤ÀÇ
  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
    • ÁÖ¿ä µ¿Çâ
  • °Å½Ã°æÁ¦ ¿äÀÎ
    • ¼¼°èÀÇ ºÎ¹®º° Àü¸Á
    • ¼¼°èÀÇ GDP ¼ºÀå Àü¸Á
    • ¼¼°èÀÇ ÇコÄɾî IT ÁöÃâ Àü¸Á
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ¿¹Ãø ¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ

Á¦3Àå ºÎ°¡°¡Ä¡ ÀλçÀÌÆ®

  • Á¦Ç° äÅà ºÐ¼®
  • ±â¼ú Æò°¡
  • ±ÔÁ¦ »óȲ
  • ¹ë·ùüÀÎ ºÐ¼®
  • ÁÖ¿ä °Å·¡¿Í ÇÕº´
  • PESTLE ºÐ¼®
  • Porter's Five Forces ºÐ¼®

Á¦4Àå °¡°Ý ºÐ¼®, 2024³â

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • Á¦Ç° °¡°Ý¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ
  • °¡°Ý ºÐ¼® : ÄÄÆ÷³ÍÆ®º°
  • Áö¿ªº° °¡°Ý°ú Á¦Ç°ÀÇ ¼±È£

Á¦5Àå ¼¼°èÀÇ ¿ø°ÝÀÇ·á ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
    • ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í Àü³â´ëºñ ¼ºÀå·ü
    • Àý´ë¾× ±âȸ
  • ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø
    • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®, 2019-2023³â
    • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, 2024-2031³â
  • ¼¼°èÀÇ ¿ø°ÝÀÇ·á ½ÃÀå Àü¸Á : ÄÄÆ÷³ÍÆ®
    • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®, ÄÄÆ÷³ÍÆ®º°, 2019-2023³â
    • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ÄÄÆ÷³ÍÆ®º°, 2024-2031³â
      • Çϵå¿þ¾î
      • ¼ÒÇÁÆ®¿þ¾î
      • ¼­ºñ½º
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÄÄÆ÷³ÍÆ®
  • ¼¼°èÀÇ ¿ø°ÝÀÇ·á ½ÃÀå Àü¸Á : µô¸®¹ö¸® ¸ðµå
    • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®, µô¸®¹ö¸® ¸ðµåº°, 2019-2023³â
    • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, µô¸®¹ö¸® ¸ðµåº°, 2024-2031³â
      • Ŭ¶ó¿ìµå ±â¹Ý µô¸®¹ö¸® ¸ðµå
      • À¥±â¹Ý µô¸®¹ö¸® ¸ðµå
      • ¿ÂÇÁ·¹¹Ì½º µô¸®¹ö¸® ¸ðµå
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : µô¸®¹ö¸® ¸ðµå
  • ¼¼°èÀÇ ¿ø°ÝÀÇ·á ½ÃÀå Àü¸Á : ¿ëµµ
    • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®, ¿ëµµº°, 2019-2023³â
    • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ¿ëµµº°, 2024-2031³â
      • ¿ø°Ý ¹æ»ç¼± Áø´Ü
      • ÅÚ·¹ ICU
      • ¿ø°ÝÀÇ·á
      • ¿ø°Ý »ó´ã
      • ¿ø°Ý ½ÉÀ庴ÇÐ
      • ¸®¸ðÆ® ¸ð´ÏÅ͸µ
      • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ¿ëµµ
  • ¼¼°èÀÇ ¿ø°ÝÀÇ·á ½ÃÀå Àü¸Á : ÃÖÁ¾»ç¿ëÀÚ
    • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2023³â
    • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ÃÖÁ¾»ç¿ëÀÚº°, 2024-2031³â
      • ÁöºÒÀÚ
      • ÇÁ·Î¹ÙÀÌ´õ
      • ȯÀÚ
      • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚ

Á¦6Àå ¼¼°èÀÇ ¿ø°ÝÀÇ·á ½ÃÀå Àü¸Á : Áö¿ª

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®, Áö¿ªº°, 2019-2023³â
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, Áö¿ªº°, 2024-2031³â
    • ºÏ¹Ì
    • À¯·´
    • µ¿¾Æ½Ã¾Æ
    • ³²¾Æ½Ã¾Æ¡¤¿À¼¼¾Æ´Ï¾Æ
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Áö¿ª

Á¦7Àå ºÏ¹ÌÀÇ ¿ø°ÝÀÇ·á ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®, ½ÃÀ庰, 2019-2023³â
    • ±¹°¡º°
    • ÄÄÆ÷³ÍÆ®º°
    • µô¸®¹ö¸® ¸ðµåº°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ±¹°¡º°, 2024-2031³â
    • ¹Ì±¹
    • ij³ª´Ù
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ÄÄÆ÷³ÍÆ®º°, 2024-2031³â
    • Çϵå¿þ¾î
    • ¼ÒÇÁÆ®¿þ¾î
    • ¼­ºñ½º
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, µô¸®¹ö¸® ¸ðµåº°, 2024-2031³â
    • Ŭ¶ó¿ìµå ±â¹Ý µô¸®¹ö¸® ¸ðµå
    • À¥±â¹Ý µô¸®¹ö¸® ¸ðµå
    • ¿ÂÇÁ·¹¹Ì½º µô¸®¹ö¸® ¸ðµå
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ¿ëµµº°, 2024-2031³â
    • ¿ø°Ý ¹æ»ç¼± Áø´Ü
    • ÅÚ·¹ ICU
    • ¿ø°ÝÀÇ·á
    • ¿ø°Ý »ó´ã
    • ¿ø°Ý ½ÉÀ庴ÇÐ
    • ¸®¸ðÆ® ¸ð´ÏÅ͸µ
    • ±âŸ
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ÃÖÁ¾»ç¿ëÀÚº°, 2024-2031³â
    • ÁöºÒÀÚ
    • ÇÁ·Î¹ÙÀÌ´õ
    • ȯÀÚ
    • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦8Àå À¯·´ÀÇ ¿ø°ÝÀÇ·á ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®, ½ÃÀ庰, 2019-2023³â
    • ±¹°¡º°
    • ÄÄÆ÷³ÍÆ®º°
    • µô¸®¹ö¸® ¸ðµåº°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ±¹°¡º°, 2024-2031³â
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ÅÍŰ
    • ±âŸ À¯·´
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ÄÄÆ÷³ÍÆ®º°, 2024-2031³â
    • Çϵå¿þ¾î
    • ¼ÒÇÁÆ®¿þ¾î
    • ¼­ºñ½º
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, µô¸®¹ö¸® ¸ðµåº°, 2024-2031³â
    • Ŭ¶ó¿ìµå ±â¹Ý µô¸®¹ö¸® ¸ðµå
    • À¥±â¹Ý µô¸®¹ö¸® ¸ðµå
    • ¿ÂÇÁ·¹¹Ì½º µô¸®¹ö¸® ¸ðµå
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ¿ëµµº°, 2024-2031³â
    • ¿ø°Ý ¹æ»ç¼± Áø´Ü
    • ÅÚ·¹ ICU
    • ¿ø°ÝÀÇ·á
    • ¿ø°Ý »ó´ã
    • ¿ø°Ý ½ÉÀ庴ÇÐ
    • ¸®¸ðÆ® ¸ð´ÏÅ͸µ
    • ±âŸ
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ÃÖÁ¾»ç¿ëÀÚº°, 2024-2031³â
    • ÁöºÒÀÚ
    • ÇÁ·Î¹ÙÀÌ´õ
    • ȯÀÚ
    • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦9Àå µ¿¾Æ½Ã¾ÆÀÇ ¿ø°ÝÀÇ·á ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®, ½ÃÀ庰, 2019-2023³â
    • ±¹°¡º°
    • ÄÄÆ÷³ÍÆ®º°
    • µô¸®¹ö¸® ¸ðµåº°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ±¹°¡º°, 2024-2031³â
    • Áß±¹
    • ÀϺ»
    • Çѱ¹
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ÄÄÆ÷³ÍÆ®º°, 2024-2031³â
    • Çϵå¿þ¾î
    • ¼ÒÇÁÆ®¿þ¾î
    • ¼­ºñ½º
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, µô¸®¹ö¸® ¸ðµåº°, 2024-2031³â
    • Ŭ¶ó¿ìµå ±â¹Ý µô¸®¹ö¸® ¸ðµå
    • À¥±â¹Ý µô¸®¹ö¸® ¸ðµå
    • ¿ÂÇÁ·¹¹Ì½º µô¸®¹ö¸® ¸ðµå
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ¿ëµµº°, 2024-2031³â
    • ¿ø°Ý ¹æ»ç¼± Áø´Ü
    • ÅÚ·¹ ICU
    • ¿ø°ÝÀÇ·á
    • ¿ø°Ý »ó´ã
    • ¿ø°Ý ½ÉÀ庴ÇÐ
    • ¸®¸ðÆ® ¸ð´ÏÅ͸µ
    • ±âŸ
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ÃÖÁ¾»ç¿ëÀÚº°, 2024-2031³â
    • ÁöºÒÀÚ
    • ÇÁ·Î¹ÙÀÌ´õ
    • ȯÀÚ
    • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦10Àå ³²¾Æ½Ã¾Æ¡¤¿À¼¼¾Æ´Ï¾ÆÀÇ ¿ø°ÝÀÇ·á ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®, ½ÃÀ庰, 2019-2023³â
    • ±¹°¡º°
    • ÄÄÆ÷³ÍÆ®º°
    • µô¸®¹ö¸® ¸ðµåº°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ±¹°¡º°, 2024-2031³â
    • Àεµ
    • µ¿³²¾Æ½Ã¾Æ
    • È£ÁÖ
    • ±âŸ ³²¾Æ½Ã¾Æ¡¤¿À¼¼¾Æ´Ï¾Æ
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ÄÄÆ÷³ÍÆ®º°, 2024-2031³â
    • Çϵå¿þ¾î
    • ¼ÒÇÁÆ®¿þ¾î
    • ¼­ºñ½º
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, µô¸®¹ö¸® ¸ðµåº°, 2024-2031³â
    • Ŭ¶ó¿ìµå ±â¹Ý µô¸®¹ö¸® ¸ðµå
    • À¥±â¹Ý µô¸®¹ö¸® ¸ðµå
    • ¿ÂÇÁ·¹¹Ì½º µô¸®¹ö¸® ¸ðµå
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ¿ëµµº°, 2024-2031³â
    • ¿ø°Ý ¹æ»ç¼± Áø´Ü
    • ÅÚ·¹ ICU
    • ¿ø°ÝÀÇ·á
    • ¿ø°Ý »ó´ã
    • ¿ø°Ý ½ÉÀ庴ÇÐ
    • ¸®¸ðÆ® ¸ð´ÏÅ͸µ
    • ±âŸ
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ÃÖÁ¾»ç¿ëÀÚº°, 2024-2031³â
    • ÁöºÒÀÚ
    • ÇÁ·Î¹ÙÀÌ´õ
    • ȯÀÚ
    • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦11Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ¿ø°ÝÀÇ·á ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®, ½ÃÀ庰, 2019-2023³â
    • ±¹°¡º°
    • ÄÄÆ÷³ÍÆ®º°
    • µô¸®¹ö¸® ¸ðµåº°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ±¹°¡º°, 2024-2031³â
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ÄÄÆ÷³ÍÆ®º°, 2024-2031³â
    • Çϵå¿þ¾î
    • ¼ÒÇÁÆ®¿þ¾î
    • ¼­ºñ½º
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, µô¸®¹ö¸® ¸ðµåº°, 2024-2031³â
    • Ŭ¶ó¿ìµå ±â¹Ý µô¸®¹ö¸® ¸ðµå
    • À¥±â¹Ý µô¸®¹ö¸® ¸ðµå
    • ¿ÂÇÁ·¹¹Ì½º µô¸®¹ö¸® ¸ðµå
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ¿ëµµº°, 2024-2031³â
    • ¿ø°Ý ¹æ»ç¼± Áø´Ü
    • ÅÚ·¹ ICU
    • ¿ø°ÝÀÇ·á
    • ¿ø°Ý »ó´ã
    • ¿ø°Ý ½ÉÀ庴ÇÐ
    • ¸®¸ðÆ® ¸ð´ÏÅ͸µ
    • ±âŸ
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ÃÖÁ¾»ç¿ëÀÚº°, 2024-2031³â
    • ÁöºÒÀÚ
    • ÇÁ·Î¹ÙÀÌ´õ
    • ȯÀÚ
    • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦12Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¿ø°ÝÀÇ·á ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®, ½ÃÀ庰, 2019-2023³â
    • ±¹°¡º°
    • ÄÄÆ÷³ÍÆ®º°
    • µô¸®¹ö¸® ¸ðµåº°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ±¹°¡º°, 2024-2031³â
    • GCC ±¹°¡
    • ÀÌÁýÆ®
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ºÏ¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ÄÄÆ÷³ÍÆ®º°, 2024-2031³â
    • Çϵå¿þ¾î
    • ¼ÒÇÁÆ®¿þ¾î
    • ¼­ºñ½º
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, µô¸®¹ö¸® ¸ðµåº°, 2024-2031³â
    • Ŭ¶ó¿ìµå ±â¹Ý µô¸®¹ö¸® ¸ðµå
    • À¥±â¹Ý µô¸®¹ö¸® ¸ðµå
    • ¿ÂÇÁ·¹¹Ì½º µô¸®¹ö¸® ¸ðµå
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ¿ëµµº°, 2024-2031³â
    • ¿ø°Ý ¹æ»ç¼± Áø´Ü
    • ÅÚ·¹ ICU
    • ¿ø°ÝÀÇ·á
    • ¿ø°Ý »ó´ã
    • ¿ø°Ý ½ÉÀ庴ÇÐ
    • ¸®¸ðÆ® ¸ð´ÏÅ͸µ
    • ±âŸ
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ÃÖÁ¾»ç¿ëÀÚº°, 2024-2031³â
    • ÁöºÒÀÚ
    • ÇÁ·Î¹ÙÀÌ´õ
    • ȯÀÚ
    • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â
  • ½ÃÀå ±¸Á¶
    • ½ÃÀ庰 °æÀï °ÝÈ­ ¸Ê
    • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ °³¿ä(»ó¼¼ - °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
    • American Well
      • °³¿ä
      • ºÎ¹®°ú Á¦Ç°
      • ÁÖ¿ä À繫 Á¤º¸
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå Àü·«
    • Honeywell International Inc.
      • °³¿ä
      • ºÎ¹®°ú Á¦Ç°
      • ÁÖ¿ä À繫 Á¤º¸
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå Àü·«
    • AMD Global Telemedicine Inc.
      • °³¿ä
      • ºÎ¹®°ú Á¦Ç°
      • ÁÖ¿ä À繫 Á¤º¸
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå Àü·«
    • GE Healthcare
      • °³¿ä
      • ºÎ¹®°ú Á¦Ç°
      • ÁÖ¿ä À繫 Á¤º¸
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå Àü·«
    • Oracle Cerner(earlier Cerner Corporation)
      • °³¿ä
      • ºÎ¹®°ú Á¦Ç°
      • ÁÖ¿ä À繫 Á¤º¸
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå Àü·«
    • Siemens Healthineers
      • °³¿ä
      • ºÎ¹®°ú Á¦Ç°
      • ÁÖ¿ä À繫 Á¤º¸
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå Àü·«
    • Teladoc Health, Inc.
      • °³¿ä
      • ºÎ¹®°ú Á¦Ç°
      • ÁÖ¿ä À繫 Á¤º¸
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå Àü·«
    • MDLIVE
      • °³¿ä
      • ºÎ¹®°ú Á¦Ç°
      • ÁÖ¿ä À繫 Á¤º¸
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå Àü·«
    • Doctor On Demand, Inc.
      • °³¿ä
      • ºÎ¹®°ú Á¦Ç°
      • ÁÖ¿ä À繫 Á¤º¸
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå Àü·«
    • Global Med
      • °³¿ä
      • ºÎ¹®°ú Á¦Ç°
      • ÁÖ¿ä À繫 Á¤º¸
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå Àü·«
    • Walmart Health
      • °³¿ä
      • ºÎ¹®°ú Á¦Ç°
      • ÁÖ¿ä À繫 Á¤º¸
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå Àü·«
    • Medtronic
      • °³¿ä
      • ºÎ¹®°ú Á¦Ç°
      • ÁÖ¿ä À繫 Á¤º¸
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå Àü·«
    • Koninklijke Philips N. V.
      • °³¿ä
      • ºÎ¹®°ú Á¦Ç°
      • ÁÖ¿ä À繫 Á¤º¸
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå Àü·«
    • GoMeyra
      • °³¿ä
      • ºÎ¹®°ú Á¦Ç°
      • ÁÖ¿ä À繫 Á¤º¸
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå Àü·«
    • Glenn Gaunt MD LLC.
      • °³¿ä
      • ºÎ¹®°ú Á¦Ç°
      • ÁÖ¿ä À繫 Á¤º¸
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå Àü·«
    • Garner Healt
      • °³¿ä
      • ºÎ¹®°ú Á¦Ç°
      • ÁÖ¿ä À繫 Á¤º¸
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå Àü·«
    • Included Health, Inc.
      • °³¿ä
      • ºÎ¹®°ú Á¦Ç°
      • ÁÖ¿ä À繫 Á¤º¸
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå Àü·«
    • BRIGHT.MD
      • °³¿ä
      • ºÎ¹®°ú Á¦Ç°
      • ÁÖ¿ä À繫 Á¤º¸
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå Àü·«
    • Sesame, Inc
      • °³¿ä
      • ºÎ¹®°ú Á¦Ç°
      • ÁÖ¿ä À繫 Á¤º¸
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå Àü·«
    • PlushCare
      • °³¿ä
      • ºÎ¹®°ú Á¦Ç°
      • ÁÖ¿ä À繫 Á¤º¸
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå Àü·«
    • TELEHEALTH INNOVATIONS, LLC
      • °³¿ä
      • ºÎ¹®°ú Á¦Ç°
      • ÁÖ¿ä À繫 Á¤º¸
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå Àü·«

Á¦14Àå ºÎ·Ï

  • Á¶»ç ¹æ¹ý
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
  • µÎÀÚ¾î¿Í ¾à¾î
KSA 24.10.31

Persistence Market Research has recently released a comprehensive report on the worldwide market for telehealth services. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global telehealth market from 2024 to 2031.

Key Insights:

  • Telehealth Market Size (2024E): US$128.6 Bn
  • Projected Market Value (2031F):US$448.9 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 15.0%

Telehealth Market - Report Scope:

Telehealth encompasses a broad spectrum of health services provided remotely, including virtual consultations, remote patient monitoring, and teletherapy. It leverages digital communication technologies to deliver health care from a distance, improving access to medical services for patients in various settings. The telehealth market caters to hospitals, clinics, and patients, offering services through various platforms, including mobile applications, websites, and dedicated telehealth systems. The market is primarily driven by the rising demand for accessible healthcare, advancements in technology, and an increasing focus on patient-centered care.

Market Growth Drivers:

The global telehealth market is propelled by several key factors, including the increasing adoption of digital health solutions, driven by the COVID-19 pandemic, which has accelerated the acceptance of telehealth services among both providers and patients. Additionally, the growing prevalence of chronic diseases necessitates ongoing patient monitoring, fostering demand for remote health solutions. Furthermore, advancements in telecommunications, such as improved internet connectivity and the proliferation of smartphones, enhance the feasibility of telehealth services. The emphasis on reducing healthcare costs and improving patient outcomes further propels market growth.

Market Restraints:

Despite promising growth prospects, the telehealth market faces challenges related to regulatory issues, reimbursement policies, and technology-related barriers. Variability in reimbursement coverage across regions and insufficient policies supporting telehealth services can hinder market adoption. Additionally, concerns regarding data security and patient privacy may deter some patients from using telehealth platforms. Addressing these regulatory and technological challenges requires collaboration between stakeholders to establish clear guidelines and standards for telehealth services.

Market Opportunities:

The telehealth market presents significant growth opportunities driven by emerging technologies, demographic trends, and evolving healthcare delivery models. The integration of artificial intelligence (AI) and machine learning (ML) into telehealth platforms can enhance diagnostic accuracy and patient management. Furthermore, the increasing acceptance of telehealth among older adults opens new avenues for market expansion. Strategic partnerships and investments in innovative telehealth solutions, including wearable technologies and telehealth applications, are essential to capitalize on emerging opportunities and sustain market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the telehealth market globally?
  • Which telehealth services and platforms are experiencing the highest adoption rates?
  • How are technological advancements reshaping the competitive landscape of the telehealth market?
  • Who are the key players contributing to the telehealth market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global telehealth market?

Competitive Intelligence and Business Strategy:

Leading players in the global telehealth market, including Teladoc Health, Amwell, and MDLIVE, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced telehealth solutions, including comprehensive care management platforms and specialized teletherapy services, catering to diverse patient needs. Collaborations with healthcare providers, insurance companies, and technology partners facilitate market access and promote technology adoption. Moreover, a strong emphasis on patient engagement, education, and improved user experience fosters market growth and enhances patient outcomes in the rapidly evolving telehealth landscape.

Key Companies Profiled:

  • Teladoc Health
  • Amwell
  • MDLIVE
  • Doxy.me
  • Doctor on Demand
  • InTouch Health
  • SimpleVisit
  • Zocdoc
  • American Well Corporation
  • HealthTap

Telehealth Industry Research Segmentation

By Component

  • Hardware
  • Software
  • Services

By Mode of Delivery

  • Cloud-Based Delivery Mode
  • Web-Based Delivery Mode
  • On-Premises Delivery Mode

By Application

  • Teleradiology
  • TeleICU
  • Telemedicine
  • Teleconsultation
  • Telecardiology
  • Remote Monitoring

By End User

  • Payers
  • Providers
  • Patients

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Telehealth Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
    • 2.3.3. Global Healthcare IT Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Technology Assessment
  • 3.3. Regulatory Landscape
  • 3.4. Value Chain Analysis
  • 3.5. Key Deals and Mergers
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Price Analysis, 2024A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Component
  • 4.4. Regional Prices and Product Preferences

5. Global Telehealth Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 5.1. Key Highlights
    • 5.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 5.1.2. Absolute $ Opportunity
  • 5.2. Market Size (US$ Mn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2023
    • 5.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2024-2031
  • 5.3. Global Telehealth Market Outlook: Component
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) Analysis, By Component, 2019-2023
    • 5.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2024-2031
      • 5.3.3.1. Hardware
      • 5.3.3.2. Software
      • 5.3.3.3. Services
  • 5.4. Market Attractiveness Analysis: Component
  • 5.5. Global Telehealth Market Outlook: Mode of Delivery
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Mn) Analysis, By Mode of Delivery, 2019-2023
    • 5.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Delivery, 2024-2031
      • 5.5.3.1. Cloud-Based Delivery Mode
      • 5.5.3.2. Web-Based Delivery Mode
      • 5.5.3.3. On-Premises Delivery Mode
  • 5.6. Market Attractiveness Analysis: Mode of Delivery
  • 5.7. Global Telehealth Market Outlook: Application
    • 5.7.1. Introduction / Key Findings
    • 5.7.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2023
    • 5.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
      • 5.7.3.1. Teleradiology
      • 5.7.3.2. TeleICU
      • 5.7.3.3. Telemedicine
      • 5.7.3.4. Teleconsultation
      • 5.7.3.5. Telecardiology
      • 5.7.3.6. Remote Monitoring
      • 5.7.3.7. Others
  • 5.8. Market Attractiveness Analysis: Application
  • 5.9. Global Telehealth Market Outlook: End User
    • 5.9.1. Introduction / Key Findings
    • 5.9.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
    • 5.9.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
      • 5.9.3.1. Payers
      • 5.9.3.2. Providers
      • 5.9.3.3. Patients
      • 5.9.3.4. Others
  • 5.10. Market Attractiveness Analysis: End User

6. Global Telehealth Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024-2031
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Telehealth Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 7.2.1. By Country
    • 7.2.2. By Component
    • 7.2.3. By Mode of Delivery
    • 7.2.4. By Application
    • 7.2.5. By End User
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2024-2031
    • 7.4.1. Hardware
    • 7.4.2. Software
    • 7.4.3. Services
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Delivery, 2024-2031
    • 7.5.1. Cloud-Based Delivery Mode
    • 7.5.2. Web-Based Delivery Mode
    • 7.5.3. On-Premises Delivery Mode
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 7.6.1. Teleradiology
    • 7.6.2. TeleICU
    • 7.6.3. Telemedicine
    • 7.6.4. Teleconsultation
    • 7.6.5. Telecardiology
    • 7.6.6. Remote Monitoring
    • 7.6.7. Others
  • 7.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 7.7.1. Payers
    • 7.7.2. Providers
    • 7.7.3. Patients
    • 7.7.4. Others
  • 7.8. Market Attractiveness Analysis

8. Europe Telehealth Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 8.2.1. By Country
    • 8.2.2. By Component
    • 8.2.3. By Mode of Delivery
    • 8.2.4. By Application
    • 8.2.5. By End User
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkiye
    • 8.3.8. Rest of Europe
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2024-2031
    • 8.4.1. Hardware
    • 8.4.2. Software
    • 8.4.3. Services
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Delivery, 2024-2031
    • 8.5.1. Cloud-Based Delivery Mode
    • 8.5.2. Web-Based Delivery Mode
    • 8.5.3. On-Premises Delivery Mode
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 8.6.1. Teleradiology
    • 8.6.2. TeleICU
    • 8.6.3. Telemedicine
    • 8.6.4. Teleconsultation
    • 8.6.5. Telecardiology
    • 8.6.6. Remote Monitoring
    • 8.6.7. Others
  • 8.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 8.7.1. Payers
    • 8.7.2. Providers
    • 8.7.3. Patients
    • 8.7.4. Others
  • 8.8. Market Attractiveness Analysis

9. East Asia Telehealth Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 9.2.1. By Country
    • 9.2.2. By Component
    • 9.2.3. By Mode of Delivery
    • 9.2.4. By Application
    • 9.2.5. By End User
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2024-2031
    • 9.4.1. Hardware
    • 9.4.2. Software
    • 9.4.3. Services
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Delivery, 2024-2031
    • 9.5.1. Cloud-Based Delivery Mode
    • 9.5.2. Web-Based Delivery Mode
    • 9.5.3. On-Premises Delivery Mode
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 9.6.1. Teleradiology
    • 9.6.2. TeleICU
    • 9.6.3. Telemedicine
    • 9.6.4. Teleconsultation
    • 9.6.5. Telecardiology
    • 9.6.6. Remote Monitoring
    • 9.6.7. Others
  • 9.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 9.7.1. Payers
    • 9.7.2. Providers
    • 9.7.3. Patients
    • 9.7.4. Others
  • 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Telehealth Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 10.2.1. By Country
    • 10.2.2. By Component
    • 10.2.3. By Mode of Delivery
    • 10.2.4. By Application
    • 10.2.5. By End User
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2024-2031
    • 10.4.1. Hardware
    • 10.4.2. Software
    • 10.4.3. Services
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Delivery, 2024-2031
    • 10.5.1. Cloud-Based Delivery Mode
    • 10.5.2. Web-Based Delivery Mode
    • 10.5.3. On-Premises Delivery Mode
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 10.6.1. Teleradiology
    • 10.6.2. TeleICU
    • 10.6.3. Telemedicine
    • 10.6.4. Teleconsultation
    • 10.6.5. Telecardiology
    • 10.6.6. Remote Monitoring
    • 10.6.7. Others
  • 10.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 10.7.1. Payers
    • 10.7.2. Providers
    • 10.7.3. Patients
    • 10.7.4. Others
  • 10.8. Market Attractiveness Analysis

11. Latin America Telehealth Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 11.2.1. By Country
    • 11.2.2. By Component
    • 11.2.3. By Mode of Delivery
    • 11.2.4. By Application
    • 11.2.5. By End User
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2024-2031
    • 11.4.1. Hardware
    • 11.4.2. Software
    • 11.4.3. Services
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Delivery, 2024-2031
    • 11.5.1. Cloud-Based Delivery Mode
    • 11.5.2. Web-Based Delivery Mode
    • 11.5.3. On-Premises Delivery Mode
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 11.6.1. Teleradiology
    • 11.6.2. TeleICU
    • 11.6.3. Telemedicine
    • 11.6.4. Teleconsultation
    • 11.6.5. Telecardiology
    • 11.6.6. Remote Monitoring
    • 11.6.7. Others
  • 11.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 11.7.1. Payers
    • 11.7.2. Providers
    • 11.7.3. Patients
    • 11.7.4. Others
  • 11.8. Market Attractiveness Analysis

12. Middle East & Africa Telehealth Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 12.2.1. By Country
    • 12.2.2. By Component
    • 12.2.3. By Mode of Delivery
    • 12.2.4. By Application
    • 12.2.5. By End User
  • 12.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2024-2031
    • 12.4.1. Hardware
    • 12.4.2. Software
    • 12.4.3. Services
  • 12.5. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Delivery, 2024-2031
    • 12.5.1. Cloud-Based Delivery Mode
    • 12.5.2. Web-Based Delivery Mode
    • 12.5.3. On-Premises Delivery Mode
  • 12.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 12.6.1. Teleradiology
    • 12.6.2. TeleICU
    • 12.6.3. Telemedicine
    • 12.6.4. Teleconsultation
    • 12.6.5. Telecardiology
    • 12.6.6. Remote Monitoring
    • 12.6.7. Others
  • 12.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 12.7.1. Payers
    • 12.7.2. Providers
    • 12.7.3. Patients
    • 12.7.4. Others
  • 12.8. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. American Well
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Product
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Honeywell International Inc.
      • 13.3.2.1. Overview
      • 13.3.2.2. Segments and Product
      • 13.3.2.3. Key Financials
      • 13.3.2.4. Market Developments
      • 13.3.2.5. Market Strategy
    • 13.3.3. AMD Global Telemedicine Inc.
      • 13.3.3.1. Overview
      • 13.3.3.2. Segments and Product
      • 13.3.3.3. Key Financials
      • 13.3.3.4. Market Developments
      • 13.3.3.5. Market Strategy
    • 13.3.4. GE Healthcare
      • 13.3.4.1. Overview
      • 13.3.4.2. Segments and Product
      • 13.3.4.3. Key Financials
      • 13.3.4.4. Market Developments
      • 13.3.4.5. Market Strategy
    • 13.3.5. Oracle Cerner (earlier Cerner Corporation)
      • 13.3.5.1. Overview
      • 13.3.5.2. Segments and Product
      • 13.3.5.3. Key Financials
      • 13.3.5.4. Market Developments
      • 13.3.5.5. Market Strategy
    • 13.3.6. Siemens Healthineers
      • 13.3.6.1. Overview
      • 13.3.6.2. Segments and Product
      • 13.3.6.3. Key Financials
      • 13.3.6.4. Market Developments
      • 13.3.6.5. Market Strategy
    • 13.3.7. Teladoc Health, Inc.
      • 13.3.7.1. Overview
      • 13.3.7.2. Segments and Product
      • 13.3.7.3. Key Financials
      • 13.3.7.4. Market Developments
      • 13.3.7.5. Market Strategy
    • 13.3.8. MDLIVE
      • 13.3.8.1. Overview
      • 13.3.8.2. Segments and Product
      • 13.3.8.3. Key Financials
      • 13.3.8.4. Market Developments
      • 13.3.8.5. Market Strategy
    • 13.3.9. Doctor On Demand, Inc.
      • 13.3.9.1. Overview
      • 13.3.9.2. Segments and Product
      • 13.3.9.3. Key Financials
      • 13.3.9.4. Market Developments
      • 13.3.9.5. Market Strategy
    • 13.3.10. Global Med
      • 13.3.10.1. Overview
      • 13.3.10.2. Segments and Product
      • 13.3.10.3. Key Financials
      • 13.3.10.4. Market Developments
      • 13.3.10.5. Market Strategy
    • 13.3.11. Walmart Health
      • 13.3.11.1. Overview
      • 13.3.11.2. Segments and Product
      • 13.3.11.3. Key Financials
      • 13.3.11.4. Market Developments
      • 13.3.11.5. Market Strategy
    • 13.3.12. Medtronic
      • 13.3.12.1. Overview
      • 13.3.12.2. Segments and Product
      • 13.3.12.3. Key Financials
      • 13.3.12.4. Market Developments
      • 13.3.12.5. Market Strategy
    • 13.3.13. Koninklijke Philips N. V.
      • 13.3.13.1. Overview
      • 13.3.13.2. Segments and Product
      • 13.3.13.3. Key Financials
      • 13.3.13.4. Market Developments
      • 13.3.13.5. Market Strategy
    • 13.3.14. GoMeyra
      • 13.3.14.1. Overview
      • 13.3.14.2. Segments and Product
      • 13.3.14.3. Key Financials
      • 13.3.14.4. Market Developments
      • 13.3.14.5. Market Strategy
    • 13.3.15. Glenn Gaunt MD LLC.
      • 13.3.15.1. Overview
      • 13.3.15.2. Segments and Product
      • 13.3.15.3. Key Financials
      • 13.3.15.4. Market Developments
      • 13.3.15.5. Market Strategy
    • 13.3.16. Garner Healt
      • 13.3.16.1. Overview
      • 13.3.16.2. Segments and Product
      • 13.3.16.3. Key Financials
      • 13.3.16.4. Market Developments
      • 13.3.16.5. Market Strategy
    • 13.3.17. Included Health, Inc.
      • 13.3.17.1. Overview
      • 13.3.17.2. Segments and Product
      • 13.3.17.3. Key Financials
      • 13.3.17.4. Market Developments
      • 13.3.17.5. Market Strategy
    • 13.3.18. BRIGHT.MD
      • 13.3.18.1. Overview
      • 13.3.18.2. Segments and Product
      • 13.3.18.3. Key Financials
      • 13.3.18.4. Market Developments
      • 13.3.18.5. Market Strategy
    • 13.3.19. Sesame, Inc
      • 13.3.19.1. Overview
      • 13.3.19.2. Segments and Product
      • 13.3.19.3. Key Financials
      • 13.3.19.4. Market Developments
      • 13.3.19.5. Market Strategy
    • 13.3.20. PlushCare
      • 13.3.20.1. Overview
      • 13.3.20.2. Segments and Product
      • 13.3.20.3. Key Financials
      • 13.3.20.4. Market Developments
      • 13.3.20.5. Market Strategy
    • 13.3.21. TELEHEALTH INNOVATIONS, LLC
      • 13.3.21.1. Overview
      • 13.3.21.2. Segments and Product
      • 13.3.21.3. Key Financials
      • 13.3.21.4. Market Developments
      • 13.3.21.5. Market Strategy

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦